Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
176
datasets available to search
ShareScore release 0.7.1
Dataset results
176 results for “Abemaciclib”
RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer
ClinicalTrials.gov study NCT03675893. IPD Sharing: NO. Countries: 1. Publications: 1.
A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer
ClinicalTrials.gov study NCT06341283. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors
ClinicalTrials.gov study NCT03220646. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer
ClinicalTrials.gov study NCT06650423. IPD Sharing: UNDECIDED. Countries: 0. Publications: 23.
A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
ClinicalTrials.gov study NCT02057133. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer
ClinicalTrials.gov study NCT02779751. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Abemaciclib, Palbociclib or Dalpiciclib Combined with Endocrine Therapy As First-line Treatment in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer
ClinicalTrials.gov study NCT06344780. IPD Sharing: Not stated. Countries: 1. Publications: 1.
TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer
ClinicalTrials.gov study NCT06001762. IPD Sharing: YES. Countries: 1. Publications: 0.
Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors
ClinicalTrials.gov study NCT02644460. IPD Sharing: NO. Countries: 1. Publications: 1.
Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer
ClinicalTrials.gov study NCT05872204. IPD Sharing: NO. Countries: 3. Publications: 1.
Abemaciclib With or Without Atezolizumab for mCRPC
ClinicalTrials.gov study NCT04751929. IPD Sharing: YES. Countries: 1. Publications: 0.
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
ClinicalTrials.gov study NCT05696626. IPD Sharing: NO. Countries: 17. Publications: 1.
Real-world Data in Patients With Breast Cancer Treated With Abemaciclib
ClinicalTrials.gov study NCT04985058. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous D
ClinicalTrials.gov study NCT03356223. IPD Sharing: Not stated. Countries: 1. Publications: 14.
Data from: Identification of reactive intermediate formation and bioactivation pathways in Abemaciclib metabolism by LC–MS/MS: in vitro metabolic investigation
Abemaciclib (Verzenio®) is approved as tyrosine kinase inhibitor (TKI) for breast cancer treatment. In this study, in vitro phase I metabolic profiling of Abemaciclib (ABC) was done using rat liver microsomes (RLMs). We checked the formation of reactive intermediates in ABC metabolism using (RLMs) in the presence of potassium cyanide (KCN) that was used as capturing agent for iminium reactive intermediates forming a stable complex that can be characterized by LC-MS/MS. Nine in vitro phase I metabolites and three cyano adducts were identified. The metabolic reactions involved in formation of these metabolites and adducts are reduction, oxidation, hydroxylation and cyanide addition. The bioactivation pathway was also proposed. Knowing the electrodeficient bioactive centre in ABC structure helped in making targeted modifications to improve its safty and retain its efficacy. Blocking or isosteric replacement of α carbon to the tertiary nitrogen atoms of piperazine ring can aid in reducing toxic side effects of ABC. No previous articles were found about in vitro metabolic profiling for ABC or structural identification of the formed reactive metabolites for ABC.
Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients
ClinicalTrials.gov study NCT04293393. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitiv
ClinicalTrials.gov study NCT05288166. IPD Sharing: YES. Countries: 24. Publications: 0.
A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
ClinicalTrials.gov study NCT04238819. IPD Sharing: YES. Countries: 8. Publications: 0.
Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149
ClinicalTrials.gov study NCT03997448. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT03130439. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.